HOME ZACKS RESEARCH PORTFOLIO COMMUNITY BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Zacks Rank     Equity Research     My Account     Help    

Zacks Education
Visit Zacks' Education section for investing guides and other free resources to make you a better investor.
Quote:
Login
Search:

 Related Links
Zacks Equity Research
Reports: All Premium Content
Reports: Buys Premium Content
By Industry Premium Content
Upgrades Premium Content
Downgrades Premium Content
Bull of the Day
Bear of the Day
Industry Outlook
Analyst Blog
Performance
About Zacks Equity Research

Subscription Services
Product Guide
Value Trader 2
Zacks Premium
Zacks Elite
Method for Trading
Breakout Trader
Champion Trader
Chart Patterns Trader
Growth Trader
Momentum Trader
Options Trader
Surprise Trader
Value Trader
Partner Newsletters
Special Reports
Top 10 Stocks
Research Wizard

Zacks Commentary: Zacks Analyst Interviews

  PRINTABLE VERSION  
Fannie, Freddie Bailout Just a First Step
With Neena Mishra
Sep 15, 2008
With the first bit of distance from which to view the U.S. government’s bailout of government-sponsored entities (GSEs) Fannie Mae (FNM) and Freddie Mac (FRE), we wanted to find out from Zacks senior finance industry analyst Neena Mishrahow much of a game-changer this is for the housing market, Wall Street overall and the U.S. economy as a whole.

What sort of immediate impact do you expect among financial companies in your coverage now that Fannie and Freddie will officially be bailed out?

The move was overall positive for the housing market and the wider economy, as it removed the uncertainty related to the government support of the GSEs, and is also likely to help bring mortgage rates down. Yet we do not expect it to lead to a recovery in the housing markets. The housing situation in the country continues to be quite grim as there is still a large supply of unsold homes in the market and an increasing number of foreclosures.

While the bailout will bring down the mortgage rates, we do not anticipate any significant increase in the buying activity in the housing markets, in view of high inflation, rising unemployment (now above 6%) and increased job losses. Further, since the banks continue to struggle with large amounts of problem assets on their balance sheets, their lending abilities will be limited and tighter lending and underwriting norms will also limit the lending activity. Thus, we also do not see housing prices stabilizing very soon.

Does this mark the beginning of a new direction in the U.S. finance business, mortgages, etc., or are there other big questions still out there?

We maintain our negative outlook on the banks and mortgage insurers and neutral outlook on the P&C and Health insurers. While we acknowledge that the GSE bailout was overall supportive for the markets, we do not see the housing markets bottoming out at present.

Many of the banks under our coverage will report higher losses, particularly related to the mortgage and residential construction portfolios, in the coming quarters. Same is the case with the mortgage insurers who will report increased losses in the U.S. mortgage operations. As a result, they will need to raise additional capital and/or eliminate/cut their dividends. We also anticipate losses related to some banks’ and insurers’ exposure to preferred stocks of the GSEs, which will likely need to be marked down.

Do you see any sub-sectors within your coverage trading at attractive valuations these days?

We suspect that the credit costs will remain elevated during the second half of 2008 and at least a part of 2009 and will continue to impact the earnings. Among the banks, we favor those which have low exposure to housing and residential construction loans and/or derive a significant portion of their earnings from fee based sources. Among the insurers also, we continue to prefer those which have superior capital levels and lower exposure to mortgage related securities in their portfolio, compared with their peers.

Are there Sells you would care to point out for investors to stay away from?

We would advise the investors to stay away from banks like National City Corp. (NCC), Wilmington Trust (WL), Zions Bancorp (ZION), Keycorp (KEY) and Comerica (CMA), and mortgage insurer PMI Group (PMI).

Neena Mishra is a senior analyst covering financial institutions and insurers for Zacks Equity Research.

       Email        Feedback          Print       


About Zacks Analyst Interviews

Zacks Equity Research employs 50 stock analysts who are experts in the industries they cover. In these articles you will discover our analyst's insights on key industries in the news along with their favorite stocks to buy and sell now.

Zacks Equity Research Home Page

ZACKS COMMENTARY: ZACKS ANALYST INTERVIEWS ARCHIVE

Machinery/Industrials
With Mario Ricchio
Nov 20, 2008
Our outlook for the machinery sector is increasingly one of caution. We are beginning to see U.S economic weakness and the credit crunch negatively impact international markets. We discuss SNP, FCX and CAT.

Retail Industry
With Rob Plaza
Nov 19, 2008
Despite the apparent values in retail stocks, there are few reasons to get excited about the retailers. Consumer spending will remain subdued for the next few quarters, and that will lead to retailers' earnings estimates declining for the next several months. We recommend Kroger and PetMed Express.

Auto & Auto Parts
With Paul Raman
Nov 18, 2008
There is a focus on automation and simplifying product lines to lower costs and benefit from economies of scale. Earnings are below expectations and have been for some time. We look at GM, F, AXL, TRW and AN.

E&C/Aerospace/Defense
With John Nelson Simon
Nov 17, 2008
It's a historical reality that, after every major skirmish since WWII, the country's direction with respect to defense spending has been altered. Whatever the new path might be, it will take time to figure it all out. We look at BA and URS.

A Pep Talk for the Market-Weary
With Charles Rotblut
Nov 13, 2008
The markets will recover. It's just a matter of when, not if. We are bullish on Axsys Technologies, Bristol-Myers Squibb and PetMed Express.


 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2008 Zacks Investment Research